BULKOVÁ, Veronika, Martin FIALA, Štěpán HAVRÁNEK, Jan ŠIMEK, Libor ŠKŇOUŘIL, Jaroslav JANUŠKA, Jindřich ŠPINAR a Dan WICHTERLE. Improvement in Quality of Life After Catheter Ablation for Paroxysmal Versus Long-standing Persistent Atrial Fibrillation: A Prospective Study With 3-Year Follow-up. Journal of the American Heart Association. Hoboken: Wiley-Blackwell, 2014, roč. 3, č. 4, s. "e000881", 15 s. ISSN 2047-9980. Dostupné z: https://dx.doi.org/10.1161/JAHA.114.000881.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Improvement in Quality of Life After Catheter Ablation for Paroxysmal Versus Long-standing Persistent Atrial Fibrillation: A Prospective Study With 3-Year Follow-up
Autoři BULKOVÁ, Veronika (203 Česká republika), Martin FIALA (203 Česká republika, domácí), Štěpán HAVRÁNEK (203 Česká republika), Jan ŠIMEK (203 Česká republika), Libor ŠKŇOUŘIL (203 Česká republika), Jaroslav JANUŠKA (203 Česká republika), Jindřich ŠPINAR (203 Česká republika, garant, domácí) a Dan WICHTERLE (203 Česká republika).
Vydání Journal of the American Heart Association, Hoboken, Wiley-Blackwell, 2014, 2047-9980.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 4.306
Kód RIV RIV/00216224:14110/14:00078476
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1161/JAHA.114.000881
UT WoS 000341296600016
Klíčová slova anglicky atrial fibrillation; long-standing persistent; paroxysmal; quality of life
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 19. 1. 2015 11:53.
Anotace
Background-Changes in quality of life (QoL) after catheter ablation for long-standing persistent atrial fibrillation (LSPAF) are not well described. We sought to compare QoL improvement after catheter ablation of paroxysmal atrial fibrillation (PAF) versus that after LSPAF. Methods and Results-A total of 261 PAF and 126 LSPAF ablation recipients were prospectively followed for arrhythmia recurrence, QoL, hospital stay, and sick leave. In PAF versus LSPAF groups, 1.3 +/- 0.6 versus 1.6 +/- 0.7 procedures were performed per patient (P<0.00001) during a 3-year follow-up. Good arrhythmia control was achieved in 86% versus 87% of patients (P=0.69) and in 69% versus 69% of patients not receiving antiarrhythmic drugs (P=0.99). The baseline QoL was better in the PAF than in the LSPAF group (European Quality of Life Group instrument self-report questionnaire visual analog scale: 66.4 +/- 14.2 versus 61.0 +/- 14.2, P=0.0005; European Quality of Life Group 3-level, 5-dimensional descriptive system: 71.4 +/- 9.2 versus 67.7 +/- 13.8, P=0.002). Postablation 3-year increase in QoL was significant in both groups (all P<0.00001) and significantly lower in PAF versus LSPAF patients (visual analog scale: +5.0 +/- 14.5 versus +10.2 +/- 12.8, P=0.001; descriptive system: +5.9 +/- 14.3 versus +9.3 +/- 13.9, P=0.03). In multivariate analysis, LSPAF, less advanced age, shorter history of AF and good arrhythmia control were consistently associated with postablation 3-year improvement in QoL. Days of hospital stay for cardiovascular reasons and days on sick leave per patient/year were significantly reduced in both groups. Conclusions-Patients with LSPAF had worse baseline QoL. The magnitude of QoL improvement after ablation of LSPAF was significantly greater compared with after ablation of PAF, particularly when good arrhythmia control was achieved without the use of antiarrhythmic drugs.
VytisknoutZobrazeno: 26. 4. 2024 13:55